Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Walid Mohamed Attiah

Zagazig University, Egypt

Title: Uropathogens among diabetic patients at Zagazig University Hospital’s outpatient clinics: prevalence and their antibiotic susceptibility patterns

Biography

Biography: Walid Mohamed Attiah

Abstract

Background: The incidence of diabetes mellitus is increasing worldwide; it has some major effects on the genitourinary system, which makes diabetic patients more liable to urinary tract infection. Despite, all these problems, antibiotics are prescribed empirically which may adversely affect antibiotic resistance so far. Therefore, the aim of this study was to identify the etiologic agents of UTI and their antibiotic susceptibility pattern among diabetic patients attending diabetic clinic of Zagazig University Hospitals.

Material & Methods: A cross-sectional study was conducted in a total of 195 diabetic patients who suffered change from June 2017 to June 2018. Demographic and clinical data were collected. Clean catch mid-stream urine samples were collected and processed for identification of uropathogen.

Results: E. coli was the commonest isolated uropathogen followed by Klebsiella pneumoniae. All the isolated bacteria were resistant to ceftriaxone but sensitive to ciprofloxacin. Gram-negative isolates demonstrated high level of sensitive to amikacin in 188 (96.4%) patients, imipenem and meropenem in 5 (2.6%) and ceftazidime in 187 (95.9%) patients. Gram-positive bacteria showed sensitive to amoxicillin-clavulanate, linezolid and vancomycin in 7 (3.6%) patients. Multidrug resistance was observed in about 30% of the isolated uropathogens.

Conclusion: Pathogens are mostly resistant to antibiotics including ceftriaxone and ampicillin with few exceptions including nitrofurantoin and sulfamethoxazole-trimethoprim.